The US Food and Drug Administration has not approved rapamycin for anti-aging therapy, but physicians have been prescribing it off-label because it has been shown to extend the healthy lifespan of ...

In the ever-evolving field of longevity and anti-aging research, chemical sciences are making significant strides, ...

The first data have now emerged from a drug Calico developed. It failed. The pill, known as fosigotifator, was not designed to slow aging itself. The Food and Drug Administration does not consider ...

Now, that dream may be inching closer to reality. Researchers are developing an anti-aging drug for dogs, and trials are showing promising results. But could the science behind this drug hold the ...

There isn’t much research supporting any one supplement in terms of its benefits for longevity—except for potentially vitamin ...

A Midtown-based therapeutics company hopes to tap the growing market of anti-aging drugs with a suite of pharmaceutical research, and investors are taking notice. Cambrian Bio recently raised $23 ...

This capability is crucial for understanding aging-related pathways ... novel targets for anti-ageing, and age-related diseases. For instance, Insilico’s leading drug candidate INS018_055 ...

Scientists from the University of Liverpool have discovered that rilmenidine, a common drug used to treat high blood pressure ...

Recently, researchers at the University of Liverpool found that rilmenidine, a common medication used to treat high blood ...

Researchers have developed AI-driven evaluation standards to enhance ageing-related interventions, aiming to improve health ...

More information: Bowen Tang, Investigating drug effects on aging and alzheimer's disease using causal inference approaches, (2025). DOI: 10.69622/27889941.v1 Provided by Karolinska Institutet ...